Connect Biopharma Holdings Limited (CNTB) tiene un P/E histórico negativo de -2.7, lo que significa que la empresa actualmente no es rentable en base a los últimos doce meses (TTM). El rendimiento de ganancias histórico es -36.51%.
Criterios demostrados por esta página:
Puntuación General SharesGrow: 57/100 con 3/7 criterios aprobados.
| Year | P/E (TTM) | Ratio PEG | Ratio P/B | Ratio P/S | Rendimiento por Dividendo |
|---|---|---|---|---|---|
| 2018 | 0.0 | 0.00 | 0.00 | 0.00 | - |
| 2019 | -43.0 | 0.00 | -23.85 | 0.00 | - |
| 2020 | -8.3 | -0.02 | -6.35 | 0.00 | - |
| 2021 | -1.3 | -0.02 | 0.99 | 0.00 | - |
| 2022 | -0.4 | 0.01 | -0.10 | 0.00 | - |
| 2023 | -1.1 | 0.01 | 0.64 | 0.00 | - |
| 2024 | -4.9 | 0.07 | 0.83 | 2.93 | - |
| 2025 | -2.8 | -0.01 | 3.74 | 2,452.52 | - |
| Year | EPS (Diluido) | Ingresos | Ingreso Neto | Margen Neto |
|---|---|---|---|---|
| 2019 | $-3.02 | $0.00 | $-24.02M | - |
| 2020 | $-14.45 | $0.00 | $-120.3M | - |
| 2021 | $-25.00 | $0.00 | $-205.21M | - |
| 2022 | $-14.50 | $0.00 | $-116.42M | - |
| 2023 | $-1.08 | $0.00 | $-59.5M | - |
| 2024 | $-0.28 | $26.03M | $-15.63M | -60% |
| 2025 | $-1.00 | $0.00 | $-55.48M | - |
| Year | EPS (Prom.) | Rango EPS | Ingresos (Prom.) | Rango de Ingresos | Analistas |
|---|---|---|---|---|---|
| 2026 | $-1.01 | $-1.08 – $-0.90 | $7.54M | $5.77M – $9.32M | 3 |
| 2027 | $-0.71 | $-0.98 – $-0.40 | $20.59M | $13.39M – $27.79M | 4 |
| 2028 | $-0.77 | $-0.81 – $-0.73 | $23.5M | $23.49M – $23.5M | 2 |
| 2029 | $-0.47 | $-0.62 – $-0.33 | $63.65M | $48.69M – $78.6M | 1 |
| 2030 | $-0.31 | $-0.40 – $-0.21 | $85.26M | $65.23M – $105.3M | 1 |
